MCID: MYL003
MIFTS: 51

Myeloid Sarcoma

Categories: Rare diseases, Cancer diseases, Blood diseases, Immune diseases

Aliases & Classifications for Myeloid Sarcoma

MalaCards integrated aliases for Myeloid Sarcoma:

Name: Myeloid Sarcoma 12 53 59 15
Granulocytic Sarcoma 12 53 59 73
Extramedullary Myeloid Tumor 12 53 59
Chloroma 12 53 59
Sarcoma, Granulocytic 76
Sarcoma Granulocytic 55
Sarcoma, Myeloid 44

Characteristics:

Orphanet epidemiological data:

59
myeloid sarcoma
Inheritance: Not applicable; Age of onset: All ages;

Classifications:



External Ids:

Disease Ontology 12 DOID:8683
ICD10 33 C92.3 C92.30
ICD9CM 35 205.3
MeSH 44 D023981
NCIt 50 C3520 C35815
Orphanet 59 ORPHA86850
UMLS via Orphanet 74 C0152276
MESH via Orphanet 45 D023981
ICD10 via Orphanet 34 C92.3
UMLS 73 C0152276

Summaries for Myeloid Sarcoma

NIH Rare Diseases : 53 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 86850Disease definitionMyeloid sarcoma is a rare solid tumor of the myelogenous cells occurring in an extramedullary site.EpidemiologyThe exact prevalence is unknown.Clinical descriptionThe clinical presentation depends on the site of involvement. Commonly involved sites of occurrence include the subperiosteal bone structures of the skull, paranasal sinuses, sternum, ribs, vertebrae, pelvis, as well as the lymph nodes and skin. Rare sites include the pancreas, heart, brain, mouth, breast, gastrointestinal and biliary tract, prostate, urinary bladder and gynecologic tract.Visit the Orphanet disease page for more resources.

MalaCards based summary : Myeloid Sarcoma, also known as granulocytic sarcoma, is related to myeloid leukemia and blastic plasmacytoid dendritic cell. An important gene associated with Myeloid Sarcoma is MPO (Myeloperoxidase), and among its related pathways/superpathways are NF-kappaB Signaling and Transcriptional misregulation in cancer. The drugs Lenograstim and Fludarabine have been mentioned in the context of this disorder. Affiliated tissues include myeloid, bone and bone marrow, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 A myeloid sarcoma (chloroma, granulocytic sarcoma,extramedullary myeloid tumor), is a solid tumor... more...

Related Diseases for Myeloid Sarcoma

Diseases related to Myeloid Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 137)
# Related Disease Score Top Affiliating Genes
1 myeloid leukemia 30.2 FLT3 KIT NPM1
2 blastic plasmacytoid dendritic cell 29.8 NCAM1 NPM1
3 dendritic cell tumor 29.7 DNTT MPO PTPRC
4 acute biphenotypic leukemia 29.1 DNTT KMT2A MPO
5 chronic myelomonocytic leukemia 28.7 FLT3 KIT
6 lymphoblastic lymphoma 28.5 DNTT KMT2A MPO PTPRC
7 leukemia, acute lymphoblastic 28.2 DNTT FLT3 KMT2A PAX5
8 leukemia, chronic myeloid 27.9 DNTT FLT3 KIT KMT2A MPO
9 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 27.7 DNTT FLT3 KIT KMT2A MPO
10 acute promyelocytic leukemia 27.4 ANPEP FLT3 MPO NCAM1 NPM1 PTPRC
11 myelodysplastic syndrome 27.0 ANPEP DNTT FLT3 KIT KMT2A NPM1
12 acute leukemia 25.9 ANPEP DNTT FLT3 KIT KMT2A MPO
13 leukemia, acute myeloid 25.3 ANPEP DNTT FLT3 KIT KMT2A MPO
14 sarcoma 10.9
15 acute myeloid leukemia with minimal differentiation 10.7 FLT3 MPO
16 acute myeloblastic leukemia without maturation 10.6 FLT3 NPM1
17 leukemia 10.5
18 chronic monocytic leukemia 10.5 MPO PTPRC
19 primary cutaneous anaplastic large cell lymphoma 10.5 NPM1 PTPRC
20 photokeratitis 10.4 DNTT PTPRC
21 epidural neoplasm 10.4 DNTT PTPRC
22 nodular lymphocyte predominant hodgkin lymphoma 10.4 PAX5 PTPRC
23 acute myeloid leukemia with t(8;21)(q22;q22) translocation 10.4 FLT3 KIT
24 hodgkin's lymphoma, lymphocytic depletion 10.4 PAX5 PTPRC
25 lymphatic system cancer 10.4 NPM1 PTPRC
26 tetrasomy 21 10.3 ANPEP DNTT
27 malignant leydig cell tumor 10.3 KIT PAX5
28 chronic eosinophilic leukemia 10.3 FLT3 KIT
29 extracutaneous mastocytoma 10.3 KIT PTPRC
30 diffuse cutaneous mastocytosis 10.3 KIT PTPRC
31 sarcomatoid squamous cell skin carcinoma 10.3 KIT PTPRC
32 8p11 myeloproliferative syndrome 10.3 FLT3 KIT
33 conventional fibrosarcoma 10.2 KIT PTPRC
34 testicular infarct 10.2 KIT PTPRC
35 gastric small cell carcinoma 10.2 NCAM1 PTPRC
36 pediatric lymphoma 10.2 DNTT NCAM1
37 cutaneous ganglioneuroma 10.2 KIT NCAM1
38 core binding factor acute myeloid leukemia 10.2 FLT3 KIT
39 angiomyoma 10.1 KIT NCAM1
40 plasma cell neoplasm 10.1 NCAM1 PTPRC
41 perineurioma 10.1 KIT NCAM1
42 rete testis neoplasm 10.1 KIT NCAM1
43 multiple cranial nerve palsy 10.1 MPO NCAM1
44 neurofibromatosis, type i 10.1 KIT NCAM1
45 malignant skin fibrous histiocytoma 10.1 KIT NCAM1
46 lung lymphoma 10.0 NCAM1 PAX5
47 acute myeloblastic leukemia with maturation 10.0 FLT3 KIT NPM1
48 anaplastic large cell lymphoma 10.0 NPM1 PAX5 PTPRC
49 large cell neuroendocrine carcinoma 10.0 KIT NCAM1
50 mn1 10.0 FLT3 KMT2A

Graphical network of the top 20 diseases related to Myeloid Sarcoma:



Diseases related to Myeloid Sarcoma

Symptoms & Phenotypes for Myeloid Sarcoma

GenomeRNAi Phenotypes related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

26 (show all 32)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 10.07 MPO
2 Increased shRNA abundance (Z-score > 2) GR00366-A-102 10.07 KIT DNTT FLT3
3 Increased shRNA abundance (Z-score > 2) GR00366-A-115 10.07 FLT3
4 Increased shRNA abundance (Z-score > 2) GR00366-A-116 10.07 FLT3
5 Increased shRNA abundance (Z-score > 2) GR00366-A-120 10.07 FLT3
6 Increased shRNA abundance (Z-score > 2) GR00366-A-121 10.07 FLT3
7 Increased shRNA abundance (Z-score > 2) GR00366-A-122 10.07 FLT3
8 Increased shRNA abundance (Z-score > 2) GR00366-A-123 10.07 FLT3 DNTT
9 Increased shRNA abundance (Z-score > 2) GR00366-A-126 10.07 MPO
10 Increased shRNA abundance (Z-score > 2) GR00366-A-138 10.07 DNTT
11 Increased shRNA abundance (Z-score > 2) GR00366-A-151 10.07 DNTT
12 Increased shRNA abundance (Z-score > 2) GR00366-A-152 10.07 KIT
13 Increased shRNA abundance (Z-score > 2) GR00366-A-157 10.07 MPO DNTT KIT
14 Increased shRNA abundance (Z-score > 2) GR00366-A-16 10.07 DNTT
15 Increased shRNA abundance (Z-score > 2) GR00366-A-163 10.07 FLT3
16 Increased shRNA abundance (Z-score > 2) GR00366-A-170 10.07 KIT
17 Increased shRNA abundance (Z-score > 2) GR00366-A-176 10.07 MPO
18 Increased shRNA abundance (Z-score > 2) GR00366-A-182 10.07 DNTT
19 Increased shRNA abundance (Z-score > 2) GR00366-A-186 10.07 MPO
20 Increased shRNA abundance (Z-score > 2) GR00366-A-197 10.07 DNTT
21 Increased shRNA abundance (Z-score > 2) GR00366-A-25 10.07 FLT3
22 Increased shRNA abundance (Z-score > 2) GR00366-A-29 10.07 MPO
23 Increased shRNA abundance (Z-score > 2) GR00366-A-30 10.07 KIT
24 Increased shRNA abundance (Z-score > 2) GR00366-A-36 10.07 MPO
25 Increased shRNA abundance (Z-score > 2) GR00366-A-42 10.07 KIT
26 Increased shRNA abundance (Z-score > 2) GR00366-A-57 10.07 MPO
27 Increased shRNA abundance (Z-score > 2) GR00366-A-7 10.07 MPO
28 Increased shRNA abundance (Z-score > 2) GR00366-A-70 10.07 MPO FLT3
29 Increased shRNA abundance (Z-score > 2) GR00366-A-73 10.07 DNTT
30 Increased shRNA abundance (Z-score > 2) GR00366-A-85 10.07 KIT
31 Increased shRNA abundance (Z-score > 2) GR00366-A-9 10.07 KIT
32 Increased shRNA abundance (Z-score > 2) GR00366-A-99 10.07 KIT

MGI Mouse Phenotypes related to Myeloid Sarcoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.91 MPO NPM1 ANPEP PAX5 DNTT FLT3
2 cellular MP:0005384 9.87 KMT2A NCAM1 NPM1 PAX5 FLT3 PTPRC
3 immune system MP:0005387 9.81 MPO NPM1 ANPEP PAX5 DNTT FLT3
4 mortality/aging MP:0010768 9.56 KMT2A MPO NCAM1 NPM1 PAX5 FLT3
5 neoplasm MP:0002006 9.1 KMT2A NPM1 PAX5 FLT3 PTPRC KIT

Drugs & Therapeutics for Myeloid Sarcoma

Drugs for Myeloid Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 98)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
2
Fludarabine Approved Phase 3,Phase 2,Phase 1 21679-14-1, 75607-67-9 30751
3
Etoposide Approved Phase 3 33419-42-0 36462
4
Hydrocortisone Approved, Vet_approved Phase 3 50-23-7 5754
5
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
6
Cytarabine Approved, Investigational Phase 3,Phase 2,Phase 1 147-94-4 6253
7
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
8
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
9
Busulfan Approved, Investigational Phase 3 55-98-1 2478
10
Idarubicin Approved Phase 3 58957-92-9 42890
11
Daunorubicin Approved Phase 3 20830-81-3 30323
12
Thioguanine Approved Phase 3 154-42-7 2723601
13
Aldesleukin Approved Phase 3,Phase 2 85898-30-2, 110942-02-4
14
Darbepoetin alfa Approved, Investigational Phase 3 11096-26-7, 209810-58-2
15
Mitoxantrone Approved, Investigational Phase 3,Phase 2 65271-80-9 4212
16
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239 406563
17
Bortezomib Approved, Investigational Phase 3 179324-69-7 387447 93860
18
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
19
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
20
Nicotinamide Approved, Investigational, Nutraceutical Phase 3 98-92-0 936
21
Niacin Approved, Investigational, Nutraceutical Phase 3 59-67-6 938
22
Butyric Acid Experimental, Investigational Phase 3 107-92-6 264
23 Dexamethasone acetate Phase 3 1177-87-3
24 Interleukin-2 Phase 3,Phase 2
25 Imatinib Mesylate Phase 3 220127-57-1 123596
26 Analgesics Phase 3,Phase 2
27 Alkylating Agents Phase 3,Phase 2
28 glucocorticoids Phase 3
29
asparaginase Phase 3
30 Folic Acid Antagonists Phase 3
31 Gastrointestinal Agents Phase 3
32 Cortisol succinate Phase 3
33 Hematinics Phase 3
34 Analgesics, Non-Narcotic Phase 3,Phase 2
35 Topoisomerase Inhibitors Phase 3,Phase 2
36 N-Methylaspartate Phase 3
37 Hormone Antagonists Phase 3
38 Dermatologic Agents Phase 3
39 Nucleic Acid Synthesis Inhibitors Phase 3
40 Hormones Phase 3
41 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3
42 Vidarabine Phosphate Phase 3,Phase 1
43 Hydrocortisone 17-butyrate 21-propionate Phase 3
44 Hydrocortisone acetate Phase 3
45 Hydrocortisone-17-butyrate Phase 3
46 Peripheral Nervous System Agents Phase 3,Phase 2
47 Anti-Bacterial Agents Phase 3,Phase 2
48 Vitamin B Complex Phase 3
49 Antibiotics, Antitubercular Phase 3,Phase 2
50 Etoposide phosphate Phase 3

Interventional clinical trials:

(show all 12)
# Name Status NCT ID Phase Drugs
1 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Completed NCT00002798 Phase 3 asparaginase;daunorubicin hydrochloride;fludarabine phosphate;therapeutic hydrocortisone;cytarabine;idarubicin;dexamethasone;thioguanine;etoposide;methotrexate;cyclophosphamide;busulfan
2 Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML Completed NCT00574873 Phase 3 Bosutinib;imatinib
3 Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Completed NCT01362140 Phase 3 Darbepoetin alfa;Placebo
4 Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Active, not recruiting NCT01371981 Phase 3 Asparaginase;Bortezomib;Cytarabine;Daunorubicin Hydrochloride;Etoposide;Mitoxantrone Hydrochloride;Sorafenib Tosylate
5 CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma Recruiting NCT02484391 Phase 2 6,8-Bis(benzylthio)octanoic Acid;Cytarabine;Mitoxantrone Hydrochloride
6 MG4101 for Refractory or Relapsed AML Recruiting NCT03349502 Phase 2 MG4101
7 Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation Recruiting NCT02790515 Phase 2 Anti-thymocyte globulin (rabbit);Blinatumomab;Cyclophosphamide;Fludarabine;G-CSF;Melphalan;Mesna;Rituximab;Tacrolimus;Thiotepa;Sirolimus
8 Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia Recruiting NCT02658487 Phase 2 Cytarabine;Vosaroxin
9 Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation Terminated NCT02259348 Phase 2 Cyclophosphamide;Fludarabine;Melphalan;Thiotepa;Rituximab
10 Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia Withdrawn NCT02791919 Phase 1 Cytarabine;Fludarabine Phosphate;WEE1 Inhibitor AZD1775
11 PET-CT in AML for Detection of Extramedullary AML Manifestations Completed NCT01278069
12 Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML) Not yet recruiting NCT03410407

Search NIH Clinical Center for Myeloid Sarcoma

Cochrane evidence based reviews: sarcoma, myeloid

Genetic Tests for Myeloid Sarcoma

Anatomical Context for Myeloid Sarcoma

MalaCards organs/tissues related to Myeloid Sarcoma:

41
Myeloid, Bone, Bone Marrow, Skin, Prostate, Lymph Node, Brain

Publications for Myeloid Sarcoma

Articles related to Myeloid Sarcoma:

(show top 50) (show all 466)
# Title Authors Year
1
RTK-RAS pathway mutation is enriched in myeloid sarcoma. ( 29789584 )
2018
2
Coexistent cutaneous myeloid sarcoma in a patient with invasive papillary carcinoma of thyroid - A rare presentation. ( 29855456 )
2018
3
Activity of decitabine in pericardial myeloid sarcoma. ( 29779081 )
2018
4
A Rare Case of Relapsed Pediatric Acute Promyelocytic Leukemia with Skin Involvement by Myeloid Sarcoma. ( 29650946 )
2018
5
A unique clinical presentation of de novo acute promyelocytic leukemia as a myeloid sarcoma of the breast. ( 29931624 )
2018
6
Intermediate dose cytarabine in treatment myeloid sarcoma of the bilateral breast after allogeneic stem cell transplantation: A case report and literature review. ( 29893346 )
2018
7
Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing. ( 28633614 )
2018
8
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration. ( 29295844 )
2018
9
Myeloid sarcoma involving the greater wing of the sphenoid bone and additional skeletal sites presenting with unilateral proptosis and fevers. ( 29557698 )
2018
10
Connecting the Dots: A Case of Myeloid Sarcoma. ( 29729239 )
2018
11
Myeloid Sarcoma Presented as Generalized Lymphadenopathy: Mimicking Malignant Lymphoma. ( 29398826 )
2018
12
Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients. ( 29602174 )
2018
13
Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study. ( 29532520 )
2018
14
A Rare Cause of Paraplegia: Myeloid Sarcoma. ( 29393854 )
2018
15
Peritoneal Myeloid Sarcoma in a Patient Treated for a Testicular Seminoma. ( 29955031 )
2018
16
Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in Japan. ( 29971602 )
2018
17
Primary Myeloid Sarcoma of the Prostate: A Case Report and Literature Review. ( 29854498 )
2018
18
Sacral Myeloid Sarcoma Manifesting as Radiculopathy in a Pediatric Patient: An Unusual Form of Myeloid Leukemia Relapse. ( 29888021 )
2018
19
Myeloid sarcoma of the small intestine in a patient without overt acute myeloid leukaemia: a challenging diagnosis of a rare condition. ( 29848520 )
2018
20
Myeloid sarcoma as a simulator of advanced ovarian cancer: A case report. ( 29666016 )
2018
21
Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall. ( 29863571 )
2018
22
Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle? ( 29680411 )
2018
23
Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-RUNX1T1 Rearrangement. ( 29151502 )
2018
24
Myeloid Sarcoma after Allogenic Stem Cell Transplantation for Acute Myeloid Leukemia: Successful Consolidation Treatment Approaches in Two Patients. ( 29682375 )
2018
25
Role of Positron Emission Tomography Imaging in Myeloid Sarcoma. ( 29430131 )
2018
26
Myeloid sarcoma with megakaryoblastic differentiation presenting as a breast mass. ( 29684340 )
2018
27
Extramedullary leukaemia presenting as cardiac myeloid sarcoma. ( 28513107 )
2017
28
How Rare Is an Oral Presentation of Myeloid Sarcoma in the Infant? ( 28943463 )
2017
29
Prostate Mass as a First Manifestation of Myeloid Sarcoma in a Patient With an Occult Acute Myeloid Leukemia-A Case Report. ( 28627396 )
2017
30
Myeloid Sarcoma in a Patient with Myelodysplastic Syndrome Associated with del(5q-): Case Report and Literature Review. ( 28801374 )
2017
31
Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. ( 28841208 )
2017
32
Primary myeloid sarcoma of small bowel. ( 28596206 )
2017
33
Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years. ( 28574302 )
2017
34
Extensive ulcerated lesions in a patient with cutaneous myeloid sarcoma responded to twice-daily fludarabine and cytarabine regimen. ( 28624256 )
2017
35
A myeloid sarcoma involving the small intestine, kidneys, mesentery, and mesenteric lymph nodes: A case report and literature review. ( 29049187 )
2017
36
Clinicoradiological characteristics, management and prognosis of primary myeloid sarcoma of the central nervous system: A report of four cases. ( 28927153 )
2017
37
Use of magnetic resonance imaging for diagnosis and after treatment of patients with myeloid sarcoma of the brain. ( 29254273 )
2017
38
Invasive Fungal Infection in Acute Myeloid Leukemia Associated with Myeloid Sarcoma of the Sinonasal Cavity: A Rare Case. ( 28607903 )
2017
39
Myeloid sarcoma: A clinicopathological study with emphasis on diagnostic difficulties. ( 29237964 )
2017
40
Myeloid sarcoma identified on liquid-based cervical cytology samples: A report of two cases. ( 28569009 )
2017
41
Myeloid sarcoma of the thyroid. ( 29236267 )
2017
42
Myeloid sarcoma causing airway obstruction. ( 28405080 )
2017
43
Isolated myeloid sarcoma of cervix: Aleukemic presentation. ( 29237986 )
2017
44
Cutaneous myeloid sarcoma associated with chronic myeloid leukemia. ( 29267445 )
2017
45
Isolated myeloid sarcoma as the first manifestation of acute myeloid leukemia: a case study. ( 29152275 )
2017
46
Intracranial Myeloid Sarcoma Metastasis Mimicking Acute Subdural Hematoma. ( 29201484 )
2017
47
Granulocytic Sarcoma of the Orbit Presenting as a Fulminant Orbitopathy in an Adult With Acute Myeloid Leukemia. ( 25853504 )
2017
48
Myeloid sarcoma of the oral cavity: A case report and review of 89 cases from the literature. ( 29075423 )
2017
49
Myeloid sarcoma of the sigmoid colon: An unusual presentation of a rare condition. ( 28606757 )
2017
50
Successful 5-azacytidine treatment of myeloid sarcoma and leukemia cutis associated with myelodysplastic syndrome: A case report and literature review. ( 28885352 )
2017

Variations for Myeloid Sarcoma

Expression for Myeloid Sarcoma

Search GEO for disease gene expression data for Myeloid Sarcoma.

Pathways for Myeloid Sarcoma

GO Terms for Myeloid Sarcoma

Cellular components related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.92 ANPEP KIT NCAM1 PTPRC

Biological processes related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.46 FLT3 KIT MPO NPM1
2 visual learning GO:0008542 9.37 KIT KMT2A
3 T cell differentiation GO:0030217 9.32 KIT PTPRC
4 positive regulation of phosphatidylinositol 3-kinase activity GO:0043552 9.26 FLT3 KIT
5 embryonic hemopoiesis GO:0035162 8.96 KIT KMT2A
6 myeloid progenitor cell differentiation GO:0002318 8.62 FLT3 KIT

Molecular functions related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 growth factor binding GO:0019838 8.62 FLT3 KIT

Sources for Myeloid Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....